Panel, continued -
FTC uses different analysis in different types of cases
Competent, reliable scientific evience required
DiStefano - biggest surprise is for how many indications ketamine is being advertised- 30 different uses being advertised beyond reasonable uses - lyme’s asthma, dementia, false claims
How to be a discerning consumer - can’t edxpect a lay person to be able to sift through an evidence based medicine analysis for any given purported use of ketamine.
(But again, Spravato plus antidepressant IS being advertised directly to consumers - Direct to consumer advertising started with Reagan.)
Berstein -
in study of telehealth and nline pharmacy - as result of pandemic move ytowards telehealth, 69% said they would be comfortable receiving a contolled substance exlcusively through tel;ehealth. How do you know if youc an trust them?
WHat are best practices?
There are some -
- Are you talking to a real person? A real clinician? Or an ai computer?
- Verifiy credentials
- Platform hipaa complaint?
- Are claims too good to be true?
- what does your health provider say?
Don’t just find an online provider on google and just assume what they are offering is legal.
Around 50% believed if search shows up first, then that is legal and okay. And that is scary.
FTC: opportunity to make money - parallel to stem cell clinics - hundreds of clinics - inherent danger in going online and looking for therapy rather than through the normal course of consultation with physician. People will be drawn to believe misleading claims
Emcee- Some people searching online have an unmet need and are looking for a solution.
Berstein - similar to medspas, stem cells, botox and wieghtloss drugs.
There are real needs and this can be a real treatment.
Emcee- drug developers also called out as making claims on their drugs options